Results are basis for CTI's Marketing Authorization Application currently under review by the EMEA SEATTLE, July 7 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC; MTA...
RNS Number:5442T Martin International Holdings PLC 22 December 2003 Martin International Holdings PLC Notifiable interest The Company was informed on 19 December 2003 that Erudite Ltd...
RNS Number:2879T Martin International Holdings PLC 15 December 2003 Martin International Holdings PLC Directors Shareholding Martin International Holdings PLC (the "Company") was...
RNS Number:2173T Martin International Holdings PLC 12 December 2003 Martin International Holdings PLC Realisation of Development Value from Surplus Property The Board of Martin...
RNS Number:1081R Martin International Holdings PLC 20 October 2003 Martin International Holdings PLC Substantial Shareholder Martin International Holdings PLC (the "Company") was...
RNS Number:9137Q Martin International Holdings PLC 15 October 2003 Martin International Holdings PLC Notifiable interest The Company was informed yesterday that Silverslaggan AB...
RNS Number:2005Q Martin International Holdings PLC 26 September 2003 MARTIN INTERNATIONAL HOLDINGS PLC ("the Group") Interim Results for the six months ended 30 June 2003 Martin...
RNS Number:7857O Martin International Holdings PLC 18 August 2003 Martin International Holdings PLC Substantial Shareholder Martin International Holdings PLC (the "Company") was...
RNS Number:7230K Martin International Holdings PLC 06 May 2003 Martin International Holdings PLC (the "Company") Annual Report and Accounts A copy of each of the Annual Report and...
RNS Number:2809K Martin International Holdings PLC 23 April 2003 Martin International Holdings PLC Holding in Company Martin International Holdings PLC (the "Company") was informed on...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관